The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
CC

c.correia

TL2 Moderator · Basel

Contributes reviews on supplier material. Based in Basel.

Joined 15 April 2025 · last posted 20h

80Posts here
3Topics
1Solutions
116Likes received
100Likes given
19Badges
55Days visited
648Posts read

Most-liked posts

  • I have no scientific background — can I still follow the analytics categories? Replied, post #3 · Start Here › Welcome · 14 May 2026 · 32 likes Worth separating two things that the opening post runs together. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed…
  • Pooling trials with different estimands — what changed since Replied, post #32 · Evidence › Meta-analyses · 3 Oct 2025 · 32 likes On post #28 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
  • Anxiety in the first weeks: drug, situation, or both Replied, post #44 · Wellbeing › Mental health · 30 Jan 2025 · 32 likes On post #40 — agreed on the reasoning, with one qualification. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
  • Reading a supplementary appendix and finding the interesting part Replied, post #69 · Evidence › Trials · 16 Jan 2025 · 32 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
  • Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #11 · Compounds › Retatrutide · 12 Jun 2025 · 31 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
  • When "no data" is the complete and final answer Replied, post #31 · Compounds › Other compounds · 30 Nov 2024 · 31 likes Coming back to post #29, because the follow-up matters more than the original answer. Why catalogue breadth is not evidence of anything: a supplier listing 500…

Where this member posts

CategoryPostsShare
Sourcing1519%
Practice1215%
Compounds1013%
Evidence810%
Nutrition & Training56%
Analytics45%

Badges earned, in order

BadgeTierGranted
First Replybronze18 Apr 2025
Basic Userbronze19 Apr 2025
Read the Guidelinesbronze20 Apr 2025
First Linkbronze21 Apr 2025
Welcomebronze30 Apr 2025
First Topicbronze7 May 2025
First Quotebronze11 May 2025
Asked Wellbronze22 May 2025
Memberbronze27 May 2025
First Tagbronze29 May 2025
Editorbronze31 May 2025
Readerbronze2 Jul 2025
Good Postsilver4 Jul 2025
First Solutionbronze15 Jul 2025
Nice Topicbronze12 Aug 2025
Nice Postbronze16 Aug 2025
Sourcedbronze19 Aug 2025
Anniversarysilver15 Apr 2026
De-escalatorgold27 Jul 2026